NIO To Surge Around 105%? Plus Keybanc Predicts $165 For This Stock

  • Keybanc raised the price target on AMETEK, Inc. AME from $145 to $165. Keybanc analyst Steve Barger maintained an Overweight rating on the stock. AMETEK shares rose 0.9% to close at $139.32 on Friday.
  • Deutsche Bank boosted the price target for NIO Inc. NIO from $20 to $21. Deutsche Bank analyst Edison Yu maintained a Buy rating on the stock. NIO shares fell 2.1% to $10.25 in pre-market trading.
  • Chardan Capital cut the price target on Iovance Biotherapeutics, Inc. IOVA from $30 to $29. Iovance Biotherapeutics shares fell 4.8% to $6.30 in pre-market trading.
  • BMO Capital boosted the price target for Post Holdings, Inc. POST from $96 to $99. Post Holdings shares dropped 0.6% to $88.45 in pre-market trading.
  • Baird slashed the price target for Twist Bioscience Corporation TWST from $56 to $33. Twist Bioscience shares fell 1.3% to $24.50 in pre-market trading.
  • JP Morgan cut the price target on Silvergate Capital Corporation SI from $80 to $50. Silvergate Capital shares dropped 0.7% to $24.73 in pre-market trading.
  • Wells Fargo boosted the price target on UGI Corporation UGI from $36 to $39. UGI shares rose 0.7% to $38.88 in pre-market trading.

Check out this: 5 On-The-Money Stock Picks For Last Week From Benzinga's Most Accurate Analysts

Don’t forget to check out our premarket coverage here .

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading IdeasPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!